Kombucha tea is a health beverage made by incubating the Kombucha "mushroom" in tea and sugar. Although therapeutic benefits have been attributed to the drink, neither its beneficial effects nor adverse side effects have been reported widely in the scientific literature. Side effects probably related to consumption of Kombucha tea are reported in four patients. Two presented with symptoms of allergic reaction, the third with jaundice, and the fourth with nausea, vomiting, and head and neck pain. In all four, use of Kombucha tea in proximity to onset of symptoms and symptom resolution on cessation of tea drinking suggest a probable etiologic association.
duration. She started drinking two glasses of Kombucha tea a day 2 months earlier. At the onset of Jaundice she stopped drinking the tea mid reduced her alcohol intake. She was taking glyburide. Physical examination revealed icterus with no stigmata of chronic liver disease, Pertinent liver test results were: aspartate aminotrmlsferase (AST), 259 U/L: alanine aminotransferase (ALT), 585 U/L: alka line phosphatase, 203 U/L: total bilirubin 5.3 mg/dL: 7-glutmnyl-transferase, 781 U/L: cholesterol. 517 mg/dL: serum albumin, 4.4 g/dL: and prothrombin time, 12.6 seconds, Serology for viral hepatitis A, B, and C was negative. as were evaluations for iron and copper overload, autoimmune hepatitis, and primary biliary cirrhosis. She had a normal platelet count and computed axial tomography scan of the abdomen was normal. Seven weeks later all abnormal laboratory values normalized. Patients with alcoholic liver disease have AST values less than 300 U/L and trivial elevations of ALT levels, resulting in the increased AST/ALT ratio characteristic of this disease. ~
Patient 2
A 51 year old woman complained of xerostomia, dizzP ness, nausea, vomiting, headache, and neck pain. She had consumed a halt-glass per day of Manchurian tea for several months. The patient was taking thyroid hormone and estro gen replacements, She was treated symptomatically for 2 days and released. On reingestion of tea, symptoms recurred and she was readmitted. Her hospital course was complicated by three syneopal episodes in addition to earlier noted symptoms. The only significant laboratory value was a caffeine level of 3.8 rag~L, 48 hours after admission. The "mushroom" was mlalyzed by gas chromatography/mass spectrometry and found to contain only caffeine (Fig. 1) .
Patients 3 and 4
Patient 3 presented with shaking, shortness of breath, and akathisia after consumption of tea and no other med ications: patient 4, with shortness of breath and throat tightness after consumption of tea an hour before and ephedrine 5 minutes before. Examination revealed hy potension, tachycardia, and tachypnea in both patients and hypothermia in one of them. All routine laboratory data were normal in both patients except for an elevated white blood cell count in patient 3. Both were treated for a presumed allergic reaction and discharged the same day. 
DISCUSSION
In all four p a t i e n t s , u s e of K o m b u c h a tea in proximity to o n s e t of s y m p t o m s a n d s y m p t o m r e s o l u t i o n on c e s s ation of tea d r i n k i n g su._~g_est a p r o b a b l e e t i o l o~c a s s o c i ation. P a t i e n t 2 rein.gested the t e a a n d s y m p t o m s r e c u r r e d .
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